Ovid Therapeutics, Inc. (OVID)
2.63
-0.17
(-6.07%)
USD |
NASDAQ |
May 15, 16:00
2.635
0.00 (0.00%)
Pre-Market: 20:00
Ovid Therapeutics Shareholders Equity (Quarterly) : 198.27M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -180.46M |
| CytomX Therapeutics, Inc. | 319.94M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 225.63M |
| Total Liabilities (Quarterly) | 27.36M |
| Debt to Equity Ratio | 0.0659 |
| Current Ratio | 10.17 |
| Net Debt Paydown Yield | 0.09% |